Literature DB >> 12940965

The immune response of regional lymph nodes during the early stages of Fasciola hepatica infection in cattle.

D V Hoyle1, D W Taylor.   

Abstract

In this study we examined regional immune responses to Fasciola hepatica infection in the natural ruminant host. Naïve cattle and those pre-exposed to a drug-abbreviated infection were subsequently challenged and lymph nodes extracted at slaughter. In vitro proliferation and cytokine production by mononuclear cells isolated from hepatic and mesenteric lymph nodes were measured after culture with whole fluke antigen (WFA). Hepatic lymph node cells had a significantly greater response to parasite antigen than mesenteric lymph node cells (P < 0.02), although there was no difference in the magnitude of the proliferative response between naïve and pre-exposed challenged cattle. Mononuclear cells from hepatic lymph nodes produced interferon gamma, interleukin 2 and interleukin 4 after culture with parasite antigen, indicative of a mixed, T helper type 0, response. Comparison of the hepatic node response to a variety of F. hepatica antigens showed that proliferation was lower after culture with cathepsin-L, than with a high molecular weight fraction, WFA or excretory-secretory antigen. Cell culture supernatant fluid from unstimulated hepatic lymph node cells showed an IgG1 response to antigens of 48, 52-70, 82, 96 and 120-190 kDa on Western blot in pre-exposed, but not naïve, challenged animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940965     DOI: 10.1046/j.1365-3024.2003.00627.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  7 in total

Review 1.  The immune response to parasitic helminths of veterinary importance and its potential manipulation for future vaccine control strategies.

Authors:  Neil Foster; Hany M Elsheikha
Journal:  Parasitol Res       Date:  2012-05       Impact factor: 2.289

2.  Th1 and Th2 cytokine gene expression in primary infection and vaccination against Fasciola gigantica in buffaloes by real-time PCR.

Authors:  Niranjan Kumar; O K Raina; Gaurav Nagar; Ved Prakash; Siju Susan Jacob
Journal:  Parasitol Res       Date:  2013-07-20       Impact factor: 2.289

3.  Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals.

Authors:  Eman El-Ahwany; Ibrahim Rabia; Faten Nagy; Mona Zoheiry; Tarek Diab; Suher Zada
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

4.  In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.

Authors:  Jose Rojas-Caraballo; Julio López-Abán; Luis Pérez del Villar; Carolina Vizcaíno; Belén Vicente; Pedro Fernández-Soto; Esther del Olmo; Manuel Alfonso Patarroyo; Antonio Muro
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

5.  Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model.

Authors:  Jose Rojas-Caraballo; Julio López-Abán; Darwin Andrés Moreno-Pérez; Belén Vicente; Pedro Fernández-Soto; Esther Del Olmo; Manuel Alfonso Patarroyo; Antonio Muro
Journal:  BMC Infect Dis       Date:  2017-01-23       Impact factor: 3.090

6.  Antigen-specific response of CD4+ T cells and hepatic lymph node cells to Fasciola hepatica-derived molecules at the early and late stage of the infection in sheep.

Authors:  Raúl Pérez-Caballero; F Javier Martínez-Moreno; Yolanda Corripio-Miyar; Tom N McNeilly; Krystyna Cwiklinski; John P Dalton; Rafael Zafra; José Pérez; Álvaro Martínez-Moreno; Leandro Buffoni
Journal:  Vet Res       Date:  2021-07-02       Impact factor: 3.683

7.  Dairy Heifers Naturally Exposed to Fasciola hepatica Develop a Type 2 Immune Response and Concomitant Suppression of Leukocyte Proliferation.

Authors:  John Graham-Brown; Catherine Hartley; Helen Clough; Aras Kadioglu; Matthew Baylis; Diana J L Williams
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.